Innovative Patient Focused Results

The Vanderbilt Specialty Pharmacy Health Outcomes and Research Program improves patient care through sound research while furthering innovation and insights within the field of specialty pharmacy.
Vanderbilt Specialty Pharmacy is affiliated with Vanderbilt University Medical Center

Research Goals


Patient Care

Improve medication access, adherence and health outcomes of Vanderbilt Specialty Pharmacy patients

Vanderbilt Specialty Pharmacy

Improve the ability to serve all specialty patients seen at Vanderbilt University Medical Center

Specialty Pharmacy Profession

Evaluate and report the value of health-system specialty pharmacy services to patients, providers and the healthcare community

Research Capabilities

We are uniquely positioned to produce rigorous, innovative, meaningful outcomes research. Our outcomes program leverages the expertise and experience of world-renowned physician champions within the Vanderbilt University Medical Center.

VSP leverages data from the patient’s electronic health record, the pharmacy dispensing system, and the specialty pharmacy patient management system to provide the most comprehensive view of the patient journey from a decision to treat through outcomes.

VSP collaborates with statisticians from the Department of Biostatistics to design and execute rigorous research studies.

VSP utilizes PharmD Health IT analysts that are both knowledgeable about clinical practice and treatment and skilled in data extraction and manipulation.

VSP provides specialty pharmacy management services for more than 5,000 patients, including patients with orphan and rare diseases.  

The integrated multidisciplinary relationship between pharmacists and specialty clinic providers extends into collaborative research and quality improvement efforts. Key opinion leaders are frequently engaged and active contributors to VSP research efforts.  

As a world-renowned academic medical center, Vanderbilt University Medical Center houses research resources that provide tools to meet any research need.  

VSP is dedicated to implementing learnings from our research back into patient care to continue to improve the quality of our services. We have a dedicated patient care improvement pharmacist to move work from research to practice.  

Vanderbilt coordinates a multisite network of health systems specialty pharmacies that collaborate to perform multisite research studies and share best practices.  

More information on the consortium can be found here: https://www.vanderbiltspecialtypharmacy.com/hssp-consortium

Our Research Program Statistics

as of September 2022

49

Peer-reviewed manuscripts

114

Posters presented

9

Podium presentations at conferences

4

Monetary research awards

Focusing on the complete patient journey

Research Bibliography

At Vanderbilt Specialty Pharmacy, we have a dedicated research team. This allows us to find groundbreaking solutions firsthand.

Student Research Program

Developed in 2016, the Vanderbilt Specialty Pharmacy Student Research Program (VSPRP) is a training program for interested student pharmacists to receive mentorship, didactic instruction, and experience in completing outcomes research.

HSSP Consortium

In 2017, the health outcomes and research team at Vanderbilt Specialty Pharmacy created a collaborative Consortium with the goal of fostering cross-site research opportunities, educational activities, and networking among health-system specialty pharmacies across the country.

AWARDS

2022

  • National Association of Specialty Pharmacy (NASP) annual conference
    • Awarded Top Poster for “Outcomes (Cost or Other)” category
      • Persistence to HIV PrEP Filled through an Integrated Health-System Specialty Pharmacy Compared to External Pharmacies
  • Academy of Managed Care Pharmacy (AMCP) Nexus 2022 
    • Platinum ribbon abstract winner
      • Financial Impact of Integrated Specialty Pharmacy Efforts to Avoid Oral Oncolytic Waste
    • Gold ribbon abstract winner 
      • Persistence to multiple sclerosis disease modifying therapies across four health system specialty pharmacies 
    • Silver ribbon abstract winner
      • Health-System specialty pharmacies ensure patients initiate new oncology treatments

2021

  • National Association of Specialty Pharmacy (NASP) annual conference
    • Awarded Top Poster for “Outcomes (Cost or Other)” category
      • Health-System Specialty Rx: PGY1 Residency Launch
  • AJHP “Articles with Impact”: Development of quality measures for use of self-injectable biologic therapy in inflammatory bowel disease: An integrated specialty pharmacy initiative
  • VUMC’s 39th Annual Graduate Medical Education Research Forum Visual Abstracts for Honorable Mention
    • Top 6 Finalist: Extended adherence and persistence to HIV PrEP in a multidisciplinary PrEP clinic.
    • Honorable Mentions: Clinical characteristics and three-month outcomes of patients prescribed alternate-dose self-injectable biologic therapy for the management of inflammatory bowel disease, Identifying misidentified nonadherence to specialty medications: comparing rates and reasons behind nonadherence, Assessing interventions to improve patient care conducted by pharmacists at an outpatient renal transplant clinic within a collaborative pharmacy practice agreement, and Rates, reasons, and timing for treatment discontinuation in patients prescribed denosumab

2020

  • American College of Gastroenterology Annual Meeting, Virtual Meeting. October, 2020
    • Awarded ACG Outstanding poster presenter award
      • Alternative subcutaneous biologic dosing in inflammatory bowel disease is delayed depending on insurance approval requirements
  • National Association of Specialty Pharmacy (NASP) annual conference, Virtual Meeting. September 2020
    • Awarded Top Poster for “Specialty Pharmacy Services” category
      • Access to direct acting antiviral therapy for recipients of solid organs from hepatitis-c-viremic donors
    • Awarded Top Poster for “Adherence” category
      • Modeling rates of primary medication nonadherence with specialty oncolytic agents

2019

  • Zitter National Patient Choice Award (2019)
  • Tennessee Society of Health System Pharmacists
    • Innovative Health-System Pharmacy Practice of the Year (2019)
  • National Association of Specialty Pharmacy (NASP) Annual Meeting & Expo
    • First place outcomes poster
      • Development of a Collaborative Pharmacy Practice Agreement to Improve Efficiency and Management of Prescribing in a Renal Transplant Clinic (Encore Presentation)
  • Academy of Managed Care and Specialty Pharmacy Annual Meeting
    • Gold ribbon abstract winners
      • A Targeted Approach to Reducing Rates of Discontinuation and Dose Reduction in Patients Receiving Sorafenib or Regorafenib
      • Development of a Collaborative Pharmacy Practice Agreement to Improve Efficiency and Management of Prescribing in a Renal Transplant Clinic

2018

  • American College of Gastroenterology Meeting
    • Recognized as Best of ACG 2018 IBD & Liver
      • Risk Factors for Non-Adherence to Biologic Therapy in Adult Patients with Inflammatory Bowel Disease (IBD): A Retrospective Analysis
  • Academy of Managed Care and Specialty Pharmacy Nexus Meeting
    • Silver Ribbon Abstract
      • Closing the Gap: Identifying Rates and Reasons for Nonadherence in a Specialty Population

2017

  • National Association of Specialty Pharmacy Annual Meeting
    • Third place abstract winner
      • Assessing the Impact of High Touch Specialty Pharmacy Services in Patients Receiving Teriparatide

Contact Us

Want to learn more about Vanderbilt Specialty Pharmacy’s Outcomes Program? Interested in partnering with us on a current or future project? We would love to hear from you!